Abstract:Abstract Background Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) infection can lead to a broad spectrum of lung diseases, including infectious diseases and tumors. Recently, with the wide application of bronchoscopes and cytopathology of bronchoalveolar lavage fluid (BALF), the diagnostic efficiency of lung diseases has improved. The present study focuses on analyzing the cytopathologic characteristics of BALF in the diagnosis of HIV/AIDS-related lung disease and comparing the lung disease spectrum between HIV and HIV-uninfected patients. Methods BALF specimens were collected from 2211 patients. Using ThinPrep liquid-based technology, the cytologic smears were prepared by staining with Hematoxylin and Eosin (HE), Gomori's methenamine silver (GMS), and Periodic Acid Schiff (PAS), acid-fast and immunocytochemical (ICC) staining. Real-time PCR was used to detect cytomegalovirus (CMV) and Mycobacterium tuberculosis (M. tuberculosis) in the remaining BALF. PCR-reverse dot hybridization was used for mycobacterial species identification. Results From the 2211 BALF specimens, 1768 (79.96%) were specimens from HIV-infected patients, and 443 (20.04%) were speciments from HIV-uninfected patients. The HIV-infected patients with a median age of 38.5 ± 11.3 years were markedly younger than the HIV-uninfected patients (52.9 ± 14.9 years) ( p < 0.01). We found that 1635 (92.5%) HIV-infected patients were males, showing a prominently higher proportion than those without HIV infection (71.1%) ( p < 0.01). Meanwhile, 1045 specific lesions were found in 1768 HIV-infected patients (59.1%), including 1034 cases of infectious diseases and 11 neoplastic lesions, also exhibiting a distinctly higher proportion compared to the HIV-uninfected patients (12.2%) ( p < 0.001). For the HIV-infected group, a distinctly higher proportion of single infection lesions (724/1768, 41%) was noted than the HIV-uninfected group (14/443, 3.2%) ( p < 0.001). Among single infection lesions, the most common was Cytomegalovirus(CMV) infection (20.9%) for the HIV-infected group, followed by Pneumocystis jiroveci (PJ) (13.0%), Fungal (3.5%), and Mycobacterial infections (3.4%), of which M. tuberculosis infection accounted for 3.1%. Double infections (300/1768, 17.0%) and Triple infections (10/1768, 0.6%) were found only among the patients with HIV. The malignancies among HIV-infected patients included adenocarcinomas (0.22%), small cell carcinomas (0.2%), squamous cell carcinomas (0.1%), and diffuse large B-cell lymphoma (0.1%). HIV-infected patients exhibited a significantly lower incidence of neoplastic lesions (0.6% vs. 9.0%) than the HIV-uninfected patients ( p < 0.001). Conclusions There was a significant difference in the spectrum of lung diseases between HIV-infected and non-infected patients diagnosed by BALF cytopathology.

Chest X-ray features of HIV-associated Pneumocystis pneumonia (PCP) in adults: a systematic review and meta-analysis

Value of imaging diagnosis of pulmonary infections in patients with acquired immunodeficiency syndrome

Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients.

[Retrospective analysis of relationship between radiological features and prognoses of pneumocystis pneumonia in non-AIDS immunocompromised patients].

CT Features of Pulmonary Cryptococcosis in HIV-Negative Patients

Diagnostic Value of Fluorescence Real-Time PCR for Pneumocystis Pneumonia in AIDS Patients

Pneumocystis jirovecii pneumonia in people living with HIV: a review

Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis

Preliminary Research: Correlation between the Appearances of CT in HIV/AIDS Patients Complicated with Tuberrulosis and Pulmonary Function

Brief Report: Alternative pulmonary function measures of emphysema in people with HIV

CT Findings of Pulmonary Tuberculosis in Patients with HIV/AIDS

Long-term Outcomes of Patients With HIV and Pneumocystis jirovecii Pneumonia in the Antiretroviral Therapy Era

Alterations in the gut microbiota of AIDS patients with pneumocystis pneumonia and correlations with the lung microbiota

Severity of radiographic changes in patients with COVID-19 pneumonia - experience from secondary-level hospital

Cytopathological analysis of bronchoalveolar lavage fluid in patients with and without HIV infection

[Clinical Analysis of Pulmonary Cryptococcosis in Non-Human Immunodeficiency Virus Infection Patients].

Clinical Manifestations and Prognostic Factors of Pneumocystis jirovecii Pneumonia without HIV

Clinical and Microbiological Characteristics of Community-Acquired Pneumonia in Human Immunodeficiency Virus-Infected Patients: A Retrospective Analysis of 79 Hiv/Aids Patients

Diagnostic Analysis of Primary Pulmonary Cryptococcosis in 90 HIV-negative Cases

Identifying predictors for bacterial and fungal coinfection on chest computed tomography in patients with Pneumocystis pneumonia

Clinical Analysis of Non-Aids Patients Pathologically Diagnosed with Pulmonary Cryptococcosis.